Moteur de recherche d’entreprises européennes
Financement de l’UE (3 911 783 €) : Biomechanics in health and disease: advanced physical tools for innovative early diagnosis Hor13/11/2018 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Biomechanics in health and disease: advanced physical tools for innovative early diagnosis
Phys2BioMed will offer excellent interdisciplinary and cross-sectoral training to a team of motivated early stage researchers (ESRs) on the application of cutting-edge physical tools for the mechanical phenotyping of cells and tissues of clinical relevance, aiming at developing novel early-diagnostic tools. The Phys2BioMed network will merge diverse competences at European level, from different fields like nanoscience and nanotechnology, physics, biology, and medicine, and will expose ESRs to the non academic and private sector. A key element of the project is the peer-to-peer collaboration of research academic institutions with industries and world-leading medical and clinical centers; these are the main actors of the global challenge against diseases, and within Phys2BioMed they will highlight unmet clinical needs, and actively cooperate with academic colleagues for developing novel diagnostic strategies. ESRs will be trained-through-research by world-leading junior and senior PIs, and will benefit of lecture courses, dedicated international schools and workshops, and topical conferences. Secondments to other nodes of the network will represent the main and more effective channel of dissemination and cross-fertilization of competences, ideas, and knowledge within the network. Besides training talented young scientists, ready to work at the boundary of diverse disciplines in the field of nanomedicine, Phys2BioMed will provide scientific and technological outcomes on biomechanics, and the mechanical determinants of diseases. Technology-wise, it will define standardized procedures for nanomechanical measurements, and the definition of the main features of new-generation instrumentation optimized for the mechanical phenotyping of clinical specimens. In the longer-term, Phys2BioMed will provide the platform and know-how to build a data bank of mechanical fingerprints of diseases, setting the ground for the development of effective early-diagnostic tools.
| Biomeca | ? |
| Centre Hospitalier Universitaire de Grenoble | 274 802 € |
| Centre National de la Recherche Scientifique CNRS | 549 604 € |
| Commissariat a L Energie Atomique et aux Energies Alternatives | 274 802 € |
| Fundacio Institut de Bioenginyeria de Catalunya | 501 810 € |
| Institut National de la Sante et de la Recherche Medicale | 274 802 € |
| OPTICS11 B.V. | 265 620 € |
| Ospedale SAN Raffaele Srl | 261 500 € |
| The Henryk Niewodniczanski Institute OF Nuclear Physics, Polish Academy OF Sciences | 227 479 € |
| Universita Degli Studi Di Milano | 522 999 € |
| UNIVERSITAET BREMEN | 505 577 € |
| UNIVERSITAET MUENSTER | 252 788 € |
https://cordis.europa.eu/project/id/812772
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Biomeca SAS, Lyon.
Les visualisations de "Biomeca - Financement de l’UE (3 911 783 €) : Biomechanics in health and disease: advanced physical tools for innovative early diagnosis"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
